![Salman Al-Mahmood](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Salman Al-Mahmood
No más puestos en curso
Historial de carrera de Salman Al-Mahmood
Antiguos cargos conocidos de Salman Al-Mahmood.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Gene Signal International SA
![]() Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Director/Miembro de la Junta | 23/09/2010 | - |
Director Técnico/Científico/I+D | 23/09/2010 | - | |
Fundador | 23/09/2010 | - |
Formación de Salman Al-Mahmood.
Université Nancy II | Doctorate Degree |
Estadísticas
Internacional
Suiza | 2 |
Francia | 2 |
Operativa
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectorial
Health Technology | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Gene Signal International SA
![]() Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Salman Al-Mahmood
- Experiencia